reversan,
Reversan,
313397-13-6,
CBLC4H10,
CHEMBL1506885,
N-[3-(4-morpholinyl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide,
N-[3-(4-Morpholinyl)propyl]-5,7-diphenyl-pyrazolo[1,5-a]pyrimidine-3-carboxamide,
MLS000570931,
AC1M59S6,
Reversan, >=98% (HPLC),
SCHEMBL14039227,
CTK8E9847,
DTXSID80367845,
REGID_for_CID_2298706,
HMS2467O12,
HMS3431M07,
BDBM50030743,
MFCD01528184,
STL504717,
ZINC19774244,
AKOS001714612,
MCULE-8438675851,
TRA0025434,
NCGC00370816-01,
SMR000193355,
RT-015398,
B7485,
FT-0674395,
J-018386,
N-(3-morpholin-4-ylpropyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide,
N-[3-(morpholin-4-yl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide,
CID2298706,